陈洪教授治疗高血压病的用药规律及经验浅析
Analysis of Professor Chen Hong’s Medication Rule and Experience in the Treatment of Hypertension
DOI: 10.12677/TCM.2023.1211484, PDF,    科研立项经费支持
作者: 周俏苑*, 陈 洪#, 黄桂琼:广州中医药大学惠州医院(惠州市中医医院),广东 惠州
关键词: 高血压病用药规律名医经验数据挖掘陈洪Hypertension Medication Rule Famous Doctor’s Experience Data Mining Chen Hong
摘要: 目的:运用数据挖掘技术系统分析陈洪教授治疗高血压病临床用药规律,总结其用药特色及临证经验。方法:收集2021年9月1日至2022年9月1日广州中医药大学惠州医院陈洪教授门诊诊治高血压病患者处方资料,应用古今医案云平台对用药频次、性味归经、证素进行统计分析,对用药进行层次聚类、关联分析及复杂网络分析。结果:共纳入263则医案,涉及患者263例,处方263首,中药106味。使用频次前10位的中药,依次为丹参、山萸肉、桑寄生、山药、天麻、牛膝、川芎、白术、半夏、茯神。药物以性平、温,味甘、苦、辛居多,多归于肝、肾二经。关联规则得出使用频次较高的药对为丹参–山萸肉、山药–丹参等。层次聚类分析得到4个聚类组。复杂网络分析得到核心处方为丹参、天麻、白术、山萸肉、山药、桑寄生、牛膝、川芎、半夏。结论:陈洪教授治疗高血压病以渗湿化痰、活血化瘀、滋补肝肾、心神同调为主要治法,并标本同治、虚实兼顾,据高血压病患者个人病情情况,灵活加减用药。本研究通过了解名医处方治疗高血压病的用药规律,为临床治疗高血压病提供借鉴与思考。
Abstract: Objective: Data mining technology is used to systematically analyze the clinical medication rules of Professor Chen Hong in the treatment of hypertension, and summarize his medication characteris-tics and clinical experience. Methods: The prescription data of hypertension patients diagnosed and treated by Professor Chen Hong in Huizhou Hospital of Guangzhou University of Chinese Medicine from September 1, 2021 to September 1, 2022 were collected. The ancient and modern medical records cloud platform was used to statistically analyze the frequency of medication, nature and flavor, meridian tropism and syndrome elements. Hierarchical clustering, correlation analysis and complex network analysis were carried out on the medication. Results: A total of 263 medical cases were included, involving 263 patients, 263 prescriptions and 106 traditional Chinese medicines. The top 10 Chinese medicines used frequently were Danshen, Shanyurou, Sangjisheng, Shanyao, Tianma, Niuxi, Chuanxiong, Baizhu, Banxia and Fushen. The drugs are mostly flat, warm, sweet, bit-ter and pungent, mostly attributed to the liver and kidney meridians. The association rules showed that the drug pairs with higher frequency of use were Danshen-Shanyurou, Shanyao-Danshen, etc. Four clustering groups were obtained by hierarchical clustering analysis. The core prescriptions obtained by complex network analysis were Danshen, Tianma, Baizhu, Shanyurou, Shanyao, Sangjisheng, Niuxi, Chuanxiong and Banxia. Conclusion: Professor Chen Hong’s treatment of hyper-tension is mainly based on the treatment of dampness and phlegm, promoting blood circulation and removing blood stasis, nourishing liver and kidney, and regulating heart and mind. According to the individual condition of patients with hypertension, he can flexibly add and subtract drugs. This study provides reference and thinking for clinical treatment of hypertension by understanding the medication rules of famous doctors in the treatment of hypertension.
文章引用:周俏苑, 陈洪, 黄桂琼. 陈洪教授治疗高血压病的用药规律及经验浅析[J]. 中医学, 2023, 12(11): 3246-3256. https://doi.org/10.12677/TCM.2023.1211484

参考文献

[1] Lai, X., Dong, Z., Wu, S., et al. (2022) Efficacy and Safety of Chinese Herbal Medicine Compared with Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial. Circulation: Cardiovas-cular Quality and Outcomes, 15, e007923. [Google Scholar] [CrossRef
[2] Hao, X. and Zhang, J.R. (2021) Research Progress of Traditional Chinese Medicine in the Treatment of Hypertension. International Journal of Clinical and Experimental Medicine Research, 5, 451-456. [Google Scholar] [CrossRef
[3] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4): 20-36, 40.
[4] Wang, Z., Chen, Z., Zhang, L., et al. (2018) Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015. Circulation, 137, 2344-2356. [Google Scholar] [CrossRef
[5] 高血压患者药物治疗管理路径编写委员会. 高血压患者药物治疗管理路径专家共识[J]. 临床药物治疗杂志, 2022, 20(1): 1-24.
[6] 王小雅, 王朋倩, 熊兴江. 《中国高血压临床实践指南》(2022版)评价与中药降血压探索[J]. 中国中药杂志, 2023, 48(17): 4819-4824.
[7] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版) [J]. 中国心血管杂志, 2019, 24(1): 24-56.
[8] 国家药典委员会编. 中华人民共和国药典一部2020年版[M]. 北京: 中国医药科技出版社, 2020.
[9] 周祯祥, 唐德才. 中药学[M]. 第10版. 北京: 中国医药科技出版社, 2016.
[10] 赵玉涵, 肖光旭, 范斯文, 等. 丹参-川芎药对治疗心脑血管疾病的作用机制及临床研究[J]. 中国动脉硬化杂志, 2022, 30(6): 461-469.
[11] Guo, R., Li, L., Su, J., et al. (2020) Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases. Drug Design, Development and Therapy, 14, 4735-4748. [Google Scholar] [CrossRef
[12] Chen, Z., Zhang, C., Gao, F., Fu, Q., Fu, C., He, Y. and Zhang, J. (2018) A Systematic Review on the Rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food and Chemical Toxicology, 119, 309-325. [Google Scholar] [CrossRef] [PubMed]
[13] (清)程国彭, 作, 吴少祯, 总主编. 医学心悟[M]. 北京: 中国医药科学技术出版社, 2020.
[14] 周海哲. 张学文教授肝热血瘀学术思想及清肝化瘀法治疗高血压病的临床研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2018.
[15] 盛鹤群. “四气五味”学说在《伤寒论》组方用药中的应用研究[D]: [硕士学位论文]. 长春: 长春中医药大学, 2018.
[16] 于彩媛. 熟地黄功效与临床运用源流考证[J]. 中国中医基础医学杂志, 2015, 21(8): 1009-1010.
[17] 李玲. 六味地黄丸的各种加减配伍及其应用特点[J]. 中医临床研究, 2015, 7(27): 146-148.
[18] 毛浩萍, 戴永娜, 陶蕊, 等. 经典方剂二至丸补肝益肾作用研究[J]. 中国药理学与毒理学杂志, 2021, 35(10): 723.
[19] 周鸿飞, 李丹, 点校. 灵枢经[M]. 郑州: 河南科学技术出版社, 2017.
[20] 何文彬, 谭一松, 主编. 素问[M]. 北京: 中国医药科技出版社, 1998.